The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Multimodal treatment in operable stage III non-small cell lung cancer using the new TNM staging classification version 8: Long term results of a pooled analysis of three SAKK trials.
 
Martin Frueh
Consulting or Advisory Role - AstraZeneca (Inst); Boehringer Ingelheim (Inst); Bristol-Myers Squibb (Inst); MSD (Inst); Roche (Inst)
Research Funding - MSD (Inst)
 
Daniel C. Betticher
No Relationships to Disclose
 
Roger Stupp
Employment - Celgene (I)
Stock and Other Ownership Interests - Celgene (I)
Consulting or Advisory Role - Celgene (Inst); Debiopharm Group (Inst); Merck KGaA (Inst); Merck Sharp & Dohme (Inst); Novartis (Inst); Novartis (Inst); Pfizer (Inst); Roche/Genentech (Inst); UCB (Inst)
Travel, Accommodations, Expenses - Novocure
 
Alexandros Xyrafas
No Relationships to Disclose
 
Solange Peters
Honoraria - AstraZeneca; Boehringer Ingelheim; Bristol-Myers Squibb; MSD; Novartis; Pfizer; Roche
Consulting or Advisory Role - Amgen; AstraZeneca; Bristol-Myers Squibb; Janssen; Merck Serono; MSD; Novartis; Pfizer; Regeneron; Roche/Genentech
Travel, Accommodations, Expenses - Bristol-Myers Squibb; Roche
 
Hans-Beat Ris
No Relationships to Disclose
 
Adrian Ochsenbein
No Relationships to Disclose
 
Ralph Alexander Schmid
No Relationships to Disclose
 
Rolf A. Stahel
No Relationships to Disclose
 
Walter Weder
No Relationships to Disclose
 
Matthias Guckenberger
Research Funding - Varian Medical Systems (Inst)
 
Sacha Rothschild
Consulting or Advisory Role - Astellas Pharma (Inst); AstraZeneca (Inst); Bayer (Inst); Boehringer Ingelheim (Inst); Bristol-Myers Squibb (Inst); Eisai (Inst); Lilly (Inst); Merck Serono (Inst); MSD Oncology (Inst); Novartis (Inst); Pfizer (Inst); Roche (Inst)
Research Funding - AstraZeneca (Inst); Boehringer Ingelheim (Inst); Bristol-Myers Squibb (Inst); Eisai (Inst)
Travel, Accommodations, Expenses - AstraZeneca; Bristol-Myers Squibb; Lilly; Merck Sharp & Dohme; Roche Pharma AG
 
Didier Lardinois
No Relationships to Disclose
 
Nicolas Mach
No Relationships to Disclose
 
Michael Thomas Mark
No Relationships to Disclose
 
Oliver Gautschi
No Relationships to Disclose
 
Sandra Thierstein
No Relationships to Disclose
 
Christine Biaggi Rudolf
No Relationships to Disclose
 
Miklos Pless
No Relationships to Disclose